VRTX Award Disclosure
Van Grunsven Jasper · SEC Form 4 · Filed Sep 10, 2026
Award
Calculated transaction value
$0
Van Grunsven Jasper EVP, Cp And Nppo
VRTX
Transaction date
Sep 8, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 2 days later
VRTX daily price context
Close on/before transaction
$528.9
Sep 8, 2026
Close before public filing
$521.12
Sep 9, 2026
Return since public filing
-0.31%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,682 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0000875320-26-000272
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vertex Pharmaceuticals Inc / Ma VRTX Current | Award | Sep 8, 2026 | $0 |